Agilon Health Inc. (AGL) Misses Q4 EPS by 4c

Agilon Health Inc. (NYSE: AGL) reported Q4 EPS of ($0.14), $0.04 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $690 million versus the consensus estimate of $664.35 million.

For earnings history and earnings-related data on Agilon Health Inc. (AGL) click here.

You May Also Be Interested In

• Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
• Goldman Sachs Downgrades Banco Comercial Portugues (BCP:LI) (BPCGF) to Neutral
• TaiMed Biologics gets TFDA drug license notice for HIV therapy Trogarzo